Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
Device with AI computing for diabetic retinopathy
2021

Share:

Device with AI computing for diabetic retinopathy

Medical device

Medimaging Integrated Solution Inc.

horus SCOPE digital imaging artificial intelligence (AI) device makes remote screening and diagnosis of diabetic retinopathy faster and more effective. It helps enhance preventive healthcare through the easier screening process, liberate eye diagnosis from the limitation of an ophthalmologist, since it can be performed by a general physician as well, maximizing the efficiency of medical resources by providing diagnosis assistance to doctors, and minimizing DR-caused blindness as symptoms can be detected at an early stage.

Date of Launch
2020
Development Time
13 - 24 months
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America, South America
Target Groups
Specific sub-group: Assist non-ophthalmologists to diagnose DR and improve the efficiency of ophthalmology clinic.

RELATED PROJECTS